Tissue Integration is a fundamental concept in regenerative medicine and tissue engineering, referring to the successful incorporation of engineered or transplanted tissues into the host organism. The goal is to achieve seamless integration between the artificial construct and the surrounding native tissue, ensuring proper functionality and avoiding adverse reactions. Scaffold materials play a crucial role in tissue integration, providing a framework for cell attachment, proliferation, and differentiation. Surface modifications, such as coatings with bioactive molecules or extracellular matrix components, are often employed to enhance the integration process. Cellular components, including stem cells or specific differentiated cell types, contribute to tissue integration by actively participating in the regeneration and remodeling of the host tissue. Vascularization is a critical aspect of tissue integration, ensuring an adequate blood supply for the survival and functionality of the engineered tissue. Mechanical properties of the construct, such as flexibility and strength, are carefully considered to promote compatibility with the surrounding tissue. Monitoring techniques, including imaging modalities and biomarker assessments, help evaluate the extent and quality of tissue integration over time. Successful tissue integration is crucial for the clinical success of various regenerative therapies, such as organ transplantation, tissue replacement, and the development of implantable medical devices. Ongoing research in tissue integration focuses on refining strategies, biomaterials, and technologies to improve the long-term outcomes and clinical applicability of tissue-engineered constructs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States